Movatterモバイル変換


[0]ホーム

URL:


 
# 617973

METHEMOGLOBINEMIA, ALPHA TYPE


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
16p13.3 Methemoglobinemia, alpha type 617973AD 3 HBA1 141800
Clinical Synopsis
 

INHERITANCE
- Autosomal dominant[SNOMEDCT:263681008,771269000][UMLS:C0443147,C1867440 HPO:HP:0000006][HPO:HP:0000006]
SKIN, NAILS, & HAIR
Skin
- Congenital, chronic cyanosis[UMLS:C5436402]
HEMATOLOGY
- Methemoglobinemia[SNOMEDCT:38959009,131171006][ICD10CM:D74.9,D74][ICD9CM:289.7][UMLS:C0025637,C5700167 HPO:HP:0012119][HPO:HP:0012119]
MISCELLANEOUS
- Onset at birth[UMLS:C1836142 HPO:HP:0003577][HPO:HP:0003577]
- Low O2 affinity hemoglobin
MOLECULAR BASIS
- Caused by mutation in the hemoglobin alpha subunit 1 gene (HBA1,141800.0092)

TEXT

A number sign (#) is used with this entry because this form of methemoglobinemia is caused by heterozygous mutation in the alpha-globin gene (HBA1;141900) that produces M hemoglobin, a methemoglobin not amenable to reduction, or a hemoglobin with an unusual susceptibility to oxidizing agents.


Description

Methemoglobinemia is a clinical condition in which more than 1% of hemoglobin is oxidized to methemoglobin, a type of hemoglobin that contains the ferric (Fe3+) form of iron. Patients with hemoglobin M are cyanotic but otherwise asymptomatic. If the mutation occurs in the hemoglobin alpha subunit, cyanosis is apparent at birth, whereas if the beta chain (141900) is affected, cyanosis appears later or intensifies when beta subunit production increases. If a newborn carries a fetal M hemoglobin (gamma subunit;142250), cyanosis disappears when the complete gamma-beta-switch occurs (summary byMansouri and Lurie, 1993).


Clinical Features

Gerald and Efron (1961) reviewed 5 different M hemoglobins, all of which caused chronic cyanosis due to the occurrence of methemoglobinemia.


Inheritance

Methemoglobinemia caused by mutation in the alpha-globin gene is inherited in an autosomal dominant manner.


Molecular Genetics

Hayashi et al. (1969) noted that 4 M hemoglobins, Hb M (Iwate) (141800.0093), Hb M (Hyde Park) (141900.0164), Hb M (Boston) (114800.0092), and Hb M (Saskatoon) (141900.0165), have a structural abnormality in the proximal or the distal histidine of the alpha or beta subunits of the Hb molecule and have the same kind of amino acid substitution, histidine to tyrosine. These 4 amino acids are critical to the binding of the heme group. A fifth variant of Hb M, Hb M (Milwaukee-1) (141900.0165), has a valine to glutamic acid substitution at a position 4 residues or one helical turn from the distal histidine.Mansouri and Lurie (1993) noted that in this Hb variant, the carboxylic group of the glutamic acid forms a bond with iron, thus stabilizing it in the oxidized form.


REFERENCES

  1. Gerald, P. S., Efron, M. L.Chemical studies of several varieties of Hb M. Proc. Nat. Acad. Sci. 47: 1758-1767, 1961. [PubMed:13897827,related citations] [Full Text]

  2. Hayashi, A., Suzuki, T., Imai, K., Morimoto, H., Watari, H.Properties of hemoglobin M, Milwaukee-1 variant and its unique characteristic. Biochim. Biophys. Acta 194: 6-15, 1969. [PubMed:4311041,related citations] [Full Text]

  3. Mansouri, A., Lurie, A. A.Methemoglobinemia. Am. J. Hemat. 42: 7-12, 1993. [PubMed:8416301,related citations] [Full Text]


Creation Date:
Carol A. Bocchini : 05/10/2018
carol : 07/24/2018
carol : 05/10/2018
carol : 05/10/2018

# 617973

METHEMOGLOBINEMIA, ALPHA TYPE


ORPHA: 330041;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
16p13.3 Methemoglobinemia, alpha type 617973 Autosomal dominant 3 HBA1 141800

TEXT

A number sign (#) is used with this entry because this form of methemoglobinemia is caused by heterozygous mutation in the alpha-globin gene (HBA1; 141900) that produces M hemoglobin, a methemoglobin not amenable to reduction, or a hemoglobin with an unusual susceptibility to oxidizing agents.


Description

Methemoglobinemia is a clinical condition in which more than 1% of hemoglobin is oxidized to methemoglobin, a type of hemoglobin that contains the ferric (Fe3+) form of iron. Patients with hemoglobin M are cyanotic but otherwise asymptomatic. If the mutation occurs in the hemoglobin alpha subunit, cyanosis is apparent at birth, whereas if the beta chain (141900) is affected, cyanosis appears later or intensifies when beta subunit production increases. If a newborn carries a fetal M hemoglobin (gamma subunit; 142250), cyanosis disappears when the complete gamma-beta-switch occurs (summary by Mansouri and Lurie, 1993).


Clinical Features

Gerald and Efron (1961) reviewed 5 different M hemoglobins, all of which caused chronic cyanosis due to the occurrence of methemoglobinemia.


Inheritance

Methemoglobinemia caused by mutation in the alpha-globin gene is inherited in an autosomal dominant manner.


Molecular Genetics

Hayashi et al. (1969) noted that 4 M hemoglobins, Hb M (Iwate) (141800.0093), Hb M (Hyde Park) (141900.0164), Hb M (Boston) (114800.0092), and Hb M (Saskatoon) (141900.0165), have a structural abnormality in the proximal or the distal histidine of the alpha or beta subunits of the Hb molecule and have the same kind of amino acid substitution, histidine to tyrosine. These 4 amino acids are critical to the binding of the heme group. A fifth variant of Hb M, Hb M (Milwaukee-1) (141900.0165), has a valine to glutamic acid substitution at a position 4 residues or one helical turn from the distal histidine. Mansouri and Lurie (1993) noted that in this Hb variant, the carboxylic group of the glutamic acid forms a bond with iron, thus stabilizing it in the oxidized form.


REFERENCES

  1. Gerald, P. S., Efron, M. L.Chemical studies of several varieties of Hb M. Proc. Nat. Acad. Sci. 47: 1758-1767, 1961. [PubMed: 13897827] [Full Text: https://doi.org/10.1073/pnas.47.11.1758]

  2. Hayashi, A., Suzuki, T., Imai, K., Morimoto, H., Watari, H.Properties of hemoglobin M, Milwaukee-1 variant and its unique characteristic. Biochim. Biophys. Acta 194: 6-15, 1969. [PubMed: 4311041] [Full Text: https://doi.org/10.1016/0005-2795(69)90173-1]

  3. Mansouri, A., Lurie, A. A.Methemoglobinemia. Am. J. Hemat. 42: 7-12, 1993. [PubMed: 8416301] [Full Text: https://doi.org/10.1002/ajh.2830420104]


Creation Date:
Carol A. Bocchini : 05/10/2018

Edit History:
carol : 07/24/2018
carol : 05/10/2018
carol : 05/10/2018



NOTE: OMIM is intended for use primarily by physicians and other professionals concerned with genetic disorders, by genetics researchers, and by advanced students in science and medicine. While the OMIM database is open to the public, users seeking information about a personal medical or genetic condition are urged to consult with a qualified physician for diagnosis and for answers to personal questions.
OMIM® and Online Mendelian Inheritance in Man® are registered trademarks of the Johns Hopkins University.
Copyright® 1966-2025 Johns Hopkins University.

NOTE: OMIM is intended for use primarily by physicians and other professionals concerned with genetic disorders, by genetics researchers, and by advanced students in science and medicine. While the OMIM database is open to the public, users seeking information about a personal medical or genetic condition are urged to consult with a qualified physician for diagnosis and for answers to personal questions.
OMIM® and Online Mendelian Inheritance in Man® are registered trademarks of the Johns Hopkins University.
Copyright® 1966-2025 Johns Hopkins University.
Printed: April 4, 2025

OMIM Donation:

Dear OMIM User,

To ensure long-term funding for the OMIM project, we have diversified our revenue stream. We are determined to keep this website freely accessible. Unfortunately, it is not free to produce. Expert curators review the literature and organize it to facilitate your work. Over 90% of the OMIM's operating expenses go to salary support for MD and PhD science writers and biocurators. Please join your colleagues by making a donation now and again in the future. Donations are an important component of our efforts to ensure long-term funding to provide you the information that you need at your fingertips.

Thank you in advance for your generous support,
Ada Hamosh, MD, MPH
Scientific Director, OMIM


[8]ページ先頭

©2009-2025 Movatter.jp